Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

European Standardised Process Approach to Cognitive Evaluation in older people

E-SPACE

During this fellowship at Dublin City University (Ireland), the researcher will enhance, significantly, the clinical utility of existing traditionally used cognitive tests, particularly as it relates to the early detection and accurate diagnosis of mild cognitive impairment (MCI) and dementia. Cognitive difficulties represent the hallmark of many...

Funding Programme
Start Date
End Date
Total Funding
€ 187 866
European Countries Involved

Exploring glycosidic neo-epitopes of degenerative hippocampal granules in aged mice and humans: implications for ageing and dementia

GLYCONEOBRAIN

Ageing is the main correlate of dementia and several other neurodegenerative diseases which currently affect more than 6 million people in Europe. Molecular understanding of these brain conditions is important for their prevention and treatment. In mice, pathological granular structures positive for periodic acid-Schiff stain have been found in the...

Funding Programme
Start Date
End Date
Total Funding
€ 183 455
European Countries Involved

Gender and Health Inequalities : from embodiment to health care cascade

GENDHI

In all European countries, social inequalities in health remain pervasive. Much research has identified a number of social stratifiers of health while others have specified the role of the health care system in contributing to the evolution of health inequalities. However, gender, as a social relation of power between men and women, is rarely...

Funding Programme
Start Date
End Date
Total Funding
€ 9 974 447
European Countries Involved

Gene Editing as Therapeutic Strategy for C9ORF72 Linked ALS/FTD

CORFEDITING

Expansion of a hexanucleotide repeat G4C2 in the non-coding region of chromosome 9 open reading frame 72 (C9orf72) is the most common genetic cause for amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). ALS is a fatal condition characterized by progressive motor deficits, degeneration of upper and lower motor neurons (MNs) and...

Funding Programme
Start Date
End Date
Total Funding
€ 149 995
European Countries Involved

Genetics to understand cellular components of Alzheimer Disease pathogenesis

CELLPHASE_AD

Alzheimer disease (AD) is a major health problem worldwide. New therapies require an accelerated translation of genetic information into mechanistic insights. Given limitations of rodent models, fully humanized models are needed to capture the complexity of the disease process. Human stem cells (iPS) provide great possibilities but are largely...

Funding Programme
Start Date
End Date
Total Funding
€ 2 374 998
European Countries Involved

High throughput mass spectrometry of single proteins in liquid environment

LIQUIDMASS

Although mass spectrometry has brought about major advancements in proteomics in the last decade, protein mass spectrometers still have important limitations. One fundamental limitation is that they require sample ionization, desorption into the gas phase and fragmentation, clearly leading to protein denaturation. Since relevant protein complexes...

Funding Programme
Start Date
End Date
Total Funding
€ 2 470 283
European Countries Involved

High-throughput vibrational fingerprinting by nanoplasmonics for disease biology

VIBRANT-BIO

Devastating diseases such as Alzheimer’s, Parkinson’s and various cancers are still without cures, continue to undermine the quality of life for millions of people and impose significant economic burdens. Misfolded toxic proteins constitute the microscopic basis of these diseases, but little is understood about their structure and biological...

Funding Programme
Start Date
End Date
Total Funding
€ 2 562 325
European Countries Involved

Holographic super-resolution micro-endoscopy for in-vivo applications

LIFEGATE

Complexity of living matter currently poses the most significant barrier to modern in-vivo microscopy. Fuelled by various branches of life sciences, the race is now to increase the penetration depth of super-resolution imaging inside living organisms. Additionally, no high-resolution in-vivo imaging technique has ever been introduced into medical...

Funding Programme
Start Date
End Date
Total Funding
€ 1 997 973
European Countries Involved

How the brain creates Mutual Understanding during Social InteraCtion

MUSIC

How can we understand one another? Our everyday conversations appear to revolve around our linguistic abilities. But creating mutual understanding involves more than formulating grammatically correct sentences. Recently, cognitive science has shown that mutual understanding relies on shared knowledge and beliefs, conceptual knowledge that is...

Funding Programme
Start Date
End Date
Total Funding
€ 260 930
European Countries Involved

How to best meet the needs of people with dementia with severe behavioural disturbances. Toward a respectful and cost-effective model

RECAGE

The RECAGE project will tackle one of the most challenging problem arising during the clinical course of dementia: the so-called Behavioural and Psychological Symptoms of Dementia (BPSD). The current state-of-the-art of the treatment of these symptoms is still unsatisfactory and there are many unmet needs in this area. The major objective of the...

Funding Programme
Start Date
End Date
Total Funding
€ 2 824 038
European Countries Involved

Hyper-emotionality after neurodegenerative loss of inhibition of the amygdala

URBACH-ALZ

I propose to test how hyper-anxiety in Alzheimer's disease (AD) patients is caused by neurodegeneration in the amygdala, our 'center of fear', by comparing with a unique group of Urbach Wiethe disease (UWD) patients with bilateral neurodegeneration of the amygdala (BLA) for which I also construct an animal model. UWD is caused by a very rare...

Funding Programme
Start Date
End Date
Total Funding
€ 173 634
European Countries Involved

ICT services for Life Improvement For the Elderly

ICT4Life

There are many efforts at European level to improve our ability to monitor health and to prevent, detect, treat and manage disease so that active and healthy ageing can be promoted. In this project, breakthrough research and radical innovation on new services for integrated care is achieved by means of an efficient and cost-effective service...

Funding Programme
Start Date
End Date
Total Funding
€ 3 433 219
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).